Video
Dr. Dason on selecting neoadjuvant or adjuvant therapy for patients with UTUC
Author(s):
“We definitely don't have a clear standard,” says Shawn Dason, MD, FRCSC.
In this video, Shawn Dason, MD, FRCSC, discusses the factors that urologists should consider when counseling patients with upper tract urothelial carcinoma about neoadjuvant and adjuvant treatment options. These insights stem from a study that was presented at the 2022 Society of Women in Urology Annual Clinical Mentoring Conference. Dason is a urologic oncologist and an assistant professor of urology at The Ohio State University in Columbus.
Related Videos
Related Content
